前列地尔冻干脂微球的制备及其体内外评价
[Abstract]:Objective to prepare alprostadil lyophilized lipid microspheres and evaluate their pharmacological properties in vitro and in vivo. Methods two-step emulsification method was used to prepare alprostadil microspheres. Freeze-dried lipid microspheres were prepared and their physicochemical properties were characterized. The stability of freeze-dried lipid microspheres was investigated with the content of particle size, main drug and related substances as the evaluation index, and the pharmacokinetic characteristics of the microspheres in Beagle dogs were studied. Results the alprostadil freeze-dried lipid microspheres were prepared with good appearance, quick redissolution rate, particle size (164.1 卤3.9nm), entrapment efficiency (92.5 卤3.3nm), prostaglandin A1 (PGA1) content (1.38 卤0.21), and no significant change in particle size after 6 months of storage. The changes of main drug and prostaglandin A1 levels were much smaller than those of Beagle dogs after intravenous injection of alprostadil injection, the half-life was (7.5 卤3.7) min, the peak time was (7.6 卤2.9) min, and the peak concentration was (105 卤40.4) ng / L ~ (-1). There was no significant difference between the pharmacokinetic parameters and the reference preparation "Kai Shi". Conclusion the alprostadil freeze-dried lipid microspheres have good physical and chemical properties, and the stability is significantly higher than that of the commercial preparations, and has the same pharmacokinetic characteristics as the alprostadil lyophilized lipid microspheres, which shows good clinical application value.
【作者单位】: 丽水市中心医院;浙江圣兆药物科技股份有限公司;
【分类号】:R943
【相似文献】
相关期刊论文 前1条
1 林起浪;郑敏枝;覃韬;田鹏辉;;烯丙基COPNA-BMI树脂微球的制备及表征[J];高分子材料科学与工程;2010年05期
相关会议论文 前5条
1 朱庆增;贾轶颖;;聚硅氧烷树脂微球形成中的同步药物装载及其控释[A];2009年全国高分子学术论文报告会论文摘要集(下册)[C];2009年
2 屠yN惺;谢木青;姚芳;方源;付爱玲;高峰;;氟比洛芬酯脂微球注射液制备及其灭菌稳定性[A];2013年中国药学大会暨第十三届中国药师周论文集[C];2013年
3 孟琳琳;叶卫江;;不同剂量前列腺素E1脂微球载体制剂治疗慢性乙型重型肝炎的临床观察[A];第7届全国疑难及重症肝病大会论文集[C];2013年
4 丁峰;李兴福;菅向东;舒强;刘花香;;前列腺素E_1、脂微球蛋白注射液治疗早期激素性股骨头坏死的初步观察[A];中华医学会全国风湿病学年会论文汇编[C];2003年
5 廖柏明;罗光汉;;前列腺素E1脂微球注射液治疗慢乙肝肝纤维化的临床观察[A];中华医学会全国第九次感染病学学术会议论文汇编[C];2006年
相关重要报纸文章 前1条
1 北京泰德制药股份有限公司副总经理 张扬;关怀生命 精益创新[N];中国医药报;2011年
相关硕士学位论文 前8条
1 叶晋生;血塞通粉针剂联合脂微球化前列腺素E1治疗下肢动脉硬化闭塞症50例临床观察[D];北京中医药大学;2010年
2 李铁岭;前列腺素E_1脂微球载体制剂治疗老年下肢动脉硬化闭塞症疗效观察[D];中国人民解放军军医进修学院;2002年
3 杨青松;PDF脂微球制剂过热水灭菌工艺的研究[D];天津大学;2004年
4 许善战;实验性肝损伤大鼠的IL-18水平以及与前列腺素E1脂微球治疗的相关性研究[D];浙江大学;2006年
5 赵明强;栓塞治疗用~(125)I树脂微球的制备方法研究[D];中国原子能科学研究院;2007年
6 刘朝祥;脂微球前列腺素E_1对重症急性胰腺炎肾损害的保护作用[D];暨南大学;2012年
7 张晓霞;前列腺素E1脂微球载体制剂对围体外循环期患者肾功能影响的观察与研究[D];山东大学;2006年
8 张小强;前列腺素E_1脂微球载体制剂对围体外循环期患者脑损伤保护作用的研究[D];南昌大学;2008年
,本文编号:2130872
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2130872.html